Product Image

Contributor Information

  • Name Irene Leigh
  • Institute Queen Mary University of London

Tool Details

  • Tool name: T11 SCC Cell Line
  • Alternate names: SCC, Squamous cell carcinoma, T11
  • Tool type: Cell Lines
  • Organism: Human
  • Tissue: Skin
  • Cancer type: Skin cancer; Skin cancer
  • Disease: Cancer
  • Model: Tumour line
  • CRISPR: No
  • Conditional: No
  • Description: The SCC series represent primary, recurrent and metastatic carcinoma. Availability of such a series from the same individual will facilitate genetic analysis of the malignant process.
  • Research area: Cancer
  • Production details: Cutaneous SCC cell line from 48 year old male. Poorly defined primary tumour from the back with germline DNA from lymphocytes. Patient had a renal transplant and was treated with Cyclosporine, Prednisolone and Azathioprine. Patient had stopped Azathioprine treatment at the time of lesional biopsy.
  • Additional notes: IC1 and IC1MET SCC Cell Lines cells are the most successful in xenografts and surface xenotransplantation (unpublished)

  • For Research Use Only

Target Details

  • Target: Squamous Cell Carcinoma

Application Details

Handling

  • Format: Frozen
  • Growth medium: Keratinocyte medium: 3:1 V/V mixture of DMEM and Ham’s F12 supplemented with 10% FBS and a cocktail of mitogens: 0.5 ug/ml hydrocortisone; 1x10-10M cholera toxin; 1.8 x 10-4 M adenine; 2 x 10–11 M liothyronine, 13 ng/ml; 5 μg/mL insulin; 10 ng/mL epidermal growth factor (EGF). FBS (10%) is routinely batch tested for enabling optimal clonal growth of cells. Culture SCC cell lines in the presence of mitotically inactivated 3T3-J2 feeder layers, which enhance proliferative capacity and reduces selective pressure on the cancer cells.
  • Storage conditions: Liquid Nitrogen
  • Shipping conditions: Dry ice
  • Characterisation tests: Genetic analysis [PMID: 30202019]
  • Mycoplasma free: Yes
  • Biosafety level: 1

Documentation

References

  •   Inman et al. 2018. Nat Commun. 9(1):3667. PMID: 30202019.
  •   The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature.